The purpose of newborn screening is to test all newborn babies for early signs of a number of treatable disorders. A blood test is done to find out whether a baby has a disease or condition for which early treatment can prevent death, mental retardation, or physical disability. About one in every thousand babies born in Australia will have one of these treatable disorders.
Each year the WA Newborn Screening Program tests more than 25,000 babies and detects about 25 who need urgent assessment and treatment.
The pamphlet Your Newborn Baby's Screening Test is essential reading for all parents before their baby has the newborn screening test. The pamphlet is available in English and five other languages.
Newborn screening tests are provided free-of-charge. The tests are not compulsory, and parents may refuse the test on behalf of their baby, but this could unnecessarily risk the baby's health.
In December 2004, the program introduced expanded newborn screening for a range of amino acid, organic acid, and fatty acid oxidation disorders. This followed the evaluation and introduction of a new screening technology called tandem mass spectrometry (MSMS). An MSMS analyser is able to quickly measure a range of amino acids and acylcarnitines in a single dried blood sample.
|General Enquiries||Phone (08) 6383 4171
Fax (08) 6383 4146
|Senior Scientist||Phone (08) 6383 4171|
|Clinical Director||Phone (08) 6383 4103|
WA Newborn Screening Program
|Postal Address||WA Newborn Screening Program
PathWest Specimen Reception
PP Block QEII Medical Centre
Locked Bag 2020
Nedlands WA 6909
|Contact Hours||8.00am to 4.30pm
Monday to Friday
(Closed public holidays)